An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Division of Medical Genetics and Metabolism, Massachusetts General Hospital for Children, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: ngold@mgh.harvard.edu.
2 Harvard Medical School, Boston, MA; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA.
3 Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Ariadne Labs, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA; Broad Institute, Boston, MA.
1 Division of Medical Genetics and Metabolism, Massachusetts General Hospital for Children, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: ngold@mgh.harvard.edu.
2 Harvard Medical School, Boston, MA; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA.
3 Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Ariadne Labs, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA; Broad Institute, Boston, MA.
Conflict of Interest Robert C. Green has received compensation for advising the following companies: Allelica, Atria, Fabric, Genome Web, Genomic Life, Verily, VinBigData; and is co-founder of Genome Medical and Nurture Genomics. Nina B. Gold is a paid consultant for RCG Consulting.
References
Mellis R, Oprych K, Scotchman E, Hill M, Chitty LS. Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: a systematic review and meta-analysis. Prenat Diagn 2022;42(6):662–685. 10.1002/pd.6115
-
DOI
-
PMC
-
PubMed
Vaknin N, Azoulay N, Tsur E, et al. High rate of abnormal findings in prenatal exome trio in low risk pregnancies and apparently normal fetuses. Prenat Diagn 2022;42(6):725–735. 10.1002/pd.6077
-
DOI
-
PubMed
Van den Veyver IB, Yaron Y, Deans ZC. International Society for prenatal diagnosis 2022 debate 3-fetal genome sequencing should be offered to all pregnant patients. Prenat Diagn 2023;43(4):428–434. 10.1002/pd.6247
-
DOI
-
PMC
-
PubMed
Van den Veyver IB, Chandler N, Wilkins-Haug LE, Wapner RJ, Chitty LS, ISPD Board of Directors. International Society for prenatal diagnosis updated Position Statement on the use of genome-wide sequencing for prenatal diagnosis. Prenat Diagn 2022;42(6):796–803. 10.1002/pd.6157
-
DOI
-
PMC
-
PubMed